首页> 外国专利> Imunoenzimu00e1tica technique (ELISA) in reverse for the quantification of specific allergens IgE

Imunoenzimu00e1tica technique (ELISA) in reverse for the quantification of specific allergens IgE

机译:反向使用免疫单抗技术(ELISA)定量特定过敏原IgE

摘要

"Imunoenzimu00e1tica technique (ELISA) in reverse for the quantification of IgE specific allergens.The present invention, ELISA, reverse.Aims to quantify levels of serum specific IgE antibodies to the allergens as a potential tool for the etiological diagnosis of hipersensiblidade in patients with the disease alu00e9rgicAs for the monitoring of allergen immunotherapy in these patients.In this way, anti allergens specific monoclonal antibodies, such as anti Der p 2.They are linked to microtitre ELISA plates to capture the relevant allergen (Der p 2) present in the crude extract of Dermatophagoides pteronyssinus,Subsequently interacts with specific IgE antibodies in samples of sera from allergic patients.These antibodies are then detected by addition of anti human IgE antibody policional biotinilado and subsequently estreptavidina peroxidase conjugate.The revelation of the reaction is performed by adding the enzyme substrate (ABTS) and the absorbance determined reader microplates at 405 nm.When compared with the conventional ELISA (CELISA) that uses the allergen Der p 2 (native or recombinant purified) directly on the awareness of microplates.Reverse ELISA proved to be more sensitive CELISA both by the percentage of positive sera (70.8% versus 52.1%) and the levels of specific IgE to Der p 2 (28.4 versus 4.5 L / ml) in asthma patients with positive skin test to d. pteronyssinus.In conclusion, reverse ELISA proved to be a sensitive method to quantify serum IgE and alternative specific allergens.Contributing to the etiological diagnosis of hypersensitivity in patients with respiratory allergic disease and provide valuable information for the monitoring of immunotherapy with peptu00eddeThe relevant or allergens.
机译:“ Imunoenzim u00e1tica技术(ELISA)用于定量IgE特异性过敏原。本发明,ELISA,反向。旨在量化针对过敏原的血清特异性IgE抗体的水平,作为潜在的病原学诊断髋关节上裂用于监测这些患者的变应原免疫疗法。通过这种方法,抗变应原特异性单克隆抗体,例如抗Der p 2,它们与微量滴定ELISA板相连以捕获相关变应原(Der p 2)存在于蕨类皮肤病的粗提物中,随后与变应性患者血清中的特定IgE抗体相互作用,然后通过加入抗人IgE抗体策略性生物素和随后的estreptavidina过氧化物酶偶联物来检测这些抗体。通过添加酶底物(ABTS)和吸光度确定的酶标仪在405 nm。与直接使用变应原Der p 2(天然或重组纯化)的常规ELISA(CELISA)相比,通过微孔板检测,反向ELISA的阳性血清百分率(70.8%)证明是更敏感的CELISA皮肤试验阳性至d的哮喘患者,Der p 2的特异性IgE水平为52.1%(28.4%,相对于4.5 L / ml)(58.4%)。总之,反向ELISA被证明是定量测定血清IgE和其他特定过敏原的灵敏方法,有助于呼吸道过敏性疾病患者超敏反应的病因学诊断,并为监测pepted的免疫疗法提供有价值的信息。过敏原。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号